XWELL, Inc. (XWEL)
- Previous Close
0.9271 - Open
0.9010 - Bid --
- Ask --
- Day's Range
0.9010 - 0.9260 - 52 Week Range
0.7000 - 2.7000 - Volume
4,210 - Avg. Volume
83,044 - Market Cap (intraday)
4.814M - Beta (5Y Monthly) 1.01
- PE Ratio (TTM)
-- - EPS (TTM)
-3.6600 - Earnings Date Aug 12, 2025 - Aug 18, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
XWELL, Inc. provides health and wellness services to travelers in the United States and internationally. It operates in four segments: XpresSpa, XpresTest, Naples Wax Center, and Treat. The XpresSpa segment provides traveler's spa services, including massage, and nail and skin care services, as well as spa and travel products. The XpresTest segment offers diagnostic COVID-19 tests to airport employees and traveling public at XpresCheck Wellness Centers in airports; operates the CDC's bio-surveillance program; and provides marketing support through HyperPointe business to various health and health-related channels. The Napple Wax Center segment offers skincare and cometic products, as well as face and body waxing services. The Treat segment provides access to wellness services for travelers at on-site centers. The company offers its services through stores and kiosks, as well as online. The company was formerly known as XpresSpa Group, Inc. and changed its name to XWELL, Inc. in October 2022. XWELL, Inc. is based in New York, New York.
www.xwell.com246
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: XWEL
View MorePerformance Overview: XWEL
Trailing total returns as of 5/21/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: XWEL
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: XWEL
View MoreValuation Measures
Market Cap
4.84M
Enterprise Value
3.81M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.13
Price/Book (mrq)
--
Enterprise Value/Revenue
0.11
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-49.72%
Return on Assets (ttm)
-23.51%
Return on Equity (ttm)
-114.86%
Revenue (ttm)
33.9M
Net Income Avi to Common (ttm)
-16.85M
Diluted EPS (ttm)
-3.6600
Balance Sheet and Cash Flow
Total Cash (mrq)
11.8M
Total Debt/Equity (mrq)
139.07%
Levered Free Cash Flow (ttm)
-6.3M